Elicio Therapeutics Inc. Revenue 2020–2022
Elicio Therapeutics Inc. annual/quarterly revenue history and growth rate from 2020 to 2023. Revenue can be defined as the amount of money a company receives from its customers in exchange for the sale of goods or services. Revenue is the top line item on an income statement from which all costs and expenses are subtracted to arrive at net income.
- Elicio Therapeutics Inc. revenue for the quarter ending March 31, 2023 was 0, a 100.00% decrease year-over-year.
- Elicio Therapeutics Inc. revenue for the twelve months ending March 31, 2023 was 2.3 M, a 28.05% decrease year-over-year.
- Elicio Therapeutics Inc. annual revenue for 2022 was 2.3 M, a 91.87% decrease from 2021.
- Elicio Therapeutics Inc. annual revenue for 2021 was 28.3 M, a 883.06% increase from 2020.
- Elicio Therapeutics Inc. annual revenue for 2020 was 2.9 M.
Elicio Therapeutics Inc. (ELTX) — Frequently Asked Questions
Elicio Therapeutics Inc. (ELTX) is a publicly traded US company. It has a market capitalization of $5M. In fiscal 2022 it reported revenue of $2M and net income of -$28M. Explore ELTX's stock price, financial statements, earnings history, margins and key ratios below.
What is Elicio Therapeutics Inc.'s market cap?
Elicio Therapeutics Inc. (ELTX) has a market capitalization of $5M.
What is the ELTX stock price?
ELTX trades at $14.30 (+0.70% on the day).
How much revenue does Elicio Therapeutics Inc. make?
Elicio Therapeutics Inc. reported revenue of $2M in fiscal 2022.
Is ELTX profitable?
In fiscal 2022, Elicio Therapeutics Inc. reported net income of -$28M.